{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:55:59Z","timestamp":1788270959385,"version":"build-2803163510"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/mjt.0b013e31815addd9","type":"journal-article","created":{"date-parts":[[2010,1,12]],"date-time":"2010-01-12T08:33:32Z","timestamp":1263285212000},"page":"e11-e23","source":"Crossref","is-referenced-by-count":24,"title":["Role of Angiotensin-Converting Enzyme Inhibitors in Vascular Modulation: Beyond the Hypertensive Effects"],"prefix":"10.1097","volume":"17","author":[{"given":"Srikanth","family":"Katragadda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit R","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-18-20210202","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"R3-18-20210202","first-page":"113","article-title":"MMWR Morb Mortal Wkly Rep.","volume":"54","year":"2005","journal-title":""},{"key":"R5-18-20210202","doi-asserted-by":"crossref","first-page":"3s","DOI":"10.1016\/S0895-7061(99)00252-6","article-title":"Risk stratification in hypertension: new insights from the Framingham Study.","volume":"13","author":"Kannel","year":"2000","journal-title":"Am J Hypertens"},{"key":"R7-18-20210202","first-page":"e85","article-title":"Heart Disease and Stroke Statistics-2006 Update: A Report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.","volume":"113","author":"Thom","year":"2006","journal-title":"Circulation"},{"key":"R8-18-20210202","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1001\/jama.293.15.1868","article-title":"","volume":"293","author":"Gregg","year":"2005","journal-title":"JAMA"},{"key":"R9-18-20210202","first-page":"147","article-title":"The renin angiotensin system.","volume":"28","author":"Inagami","year":"1994","journal-title":"Essays Biochem"},{"key":"R10-18-20210202","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/ndt\/15.5.637","article-title":"Renal and systemic effects of continued treatment with rennin inhibitor remikiren in hypertensive patients with normal and impaired renal function.","volume":"15","author":"Van Paasen","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"R11-18-20210202","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1097\/00004872-199816120-00012","article-title":"Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation inessential hypertension.","volume":"16","author":"Grassi","year":"1998","journal-title":"J Hypertens"},{"key":"R12-18-20210202","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJM199304013281303","article-title":"Single drug therapy for hypertension in men.","volume":"328","author":"Materson","year":"1993","journal-title":"N Engl J Med"},{"key":"R13-18-20210202","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"R14-18-20210202","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMoa021716","article-title":"Comparison of angiotensin converting enzyme inhibitors and diuretics for hypertension in the elderly.","volume":"348","author":"Wing","year":"2003","journal-title":"N Engl J Med"},{"key":"R15-18-20210202","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1152\/ajplegacy.1971.220.2.477","article-title":"Direct myocardial effects of angiotensin II.","volume":"220","author":"Dempsey","year":"1971","journal-title":"Am J Physiol"},{"key":"R17-18-20210202","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"key":"R18-18-20210202","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure.","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"key":"R19-18-20210202","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1161\/01.CIR.100.23.2312","article-title":"Armstrong PW, et al, for the ATLAS investigators. Comparative effects of low doses and high doses of angiotensin converting enzyme inhibitor, Lisinopril, on morbidity and mortality in chronic heart failure.","volume":"100","author":"Packer","year":"1999","journal-title":"Circulation"},{"key":"R20-18-20210202","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archinte.161.2.165","article-title":"Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS Trial.","volume":"161","author":"Massie","year":"2001","journal-title":"Arch Int Med"},{"key":"R21-18-20210202","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.","volume":"327","year":"1992","journal-title":"N Engl J Med"},{"key":"R22-18-20210202","first-page":"669","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction.","volume":"327","author":"Pfeffer","year":"1992","journal-title":"The SAVE Investigators: N Engl J Med"},{"key":"R23-18-20210202","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0002-9149(01)01461-8","article-title":"The Quinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function.","volume":"87","author":"Pitt","year":"2001","journal-title":"Am J Cardiol"},{"issue":"Suppl","key":"R24-18-20210202","doi-asserted-by":"crossref","first-page":"141S","DOI":"10.1111\/j.1365-2125.1989.tb03589.x","article-title":"Angiotensin and the remodeling of the myocardium.","volume":"28","author":"Weber","year":"1989","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl","key":"R25-18-20210202","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1097\/00004872-199204001-00007","article-title":"Prevention of structural changes in the heart in hypertension by angiotensin enzyme inhibition.","author":"Tan","year":"1992","journal-title":"J Hypertens"},{"key":"R26-18-20210202","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1161\/01.CIR.91.10.2573","article-title":"Koilpillai C, et al, for the SOLVD Investigators. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction: results of the SOLVD echocardiography substudy.","volume":"91","author":"Greenberg","year":"1995","journal-title":"Circulation"},{"key":"R27-18-20210202","first-page":"394","article-title":"ISIS-4: randomized study of oral captopril in over 50,000 patients with suspected acute myocardial infarction [Abstract].","volume":"88","year":"1993","journal-title":"Circulation"},{"key":"R29-18-20210202","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","article-title":"Trandolapril Cardiac Evaluation (TRACE) Study Group. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction.","volume":"333","author":"Kober","year":"1995","journal-title":"N Engl J Med"},{"key":"R30-18-20210202","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1056\/NEJMoa042739","article-title":"The PEACE Trial Investigators. Angiotensin-converting-enzyme inhibition in stable coronary artery disease.","volume":"351","author":"Braunwald","year":"2004","journal-title":"N Engl J Med"},{"key":"R31-18-20210202","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJM199501123320203","article-title":"The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators.","volume":"332","author":"Ambrosioni","year":"1995","journal-title":"N Engl J Med"},{"key":"R33-18-20210202","first-page":"434","article-title":"Diabetes Care.","volume":"16","author":"Stamler","year":"1993","journal-title":""},{"key":"R34-18-20210202","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMoa042167","article-title":"Preventing microalbuminuria in type 2 diabetes.","volume":"351","author":"Ruggenenti","year":"2004","journal-title":"N Engl J Med"},{"key":"R35-18-20210202","first-page":"253","article-title":"Heart Outcomes Prevention Evaluation Study Investigators.","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"R36-18-20210202","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJMcp013462","article-title":"Non diabetic kidney disease.","volume":"347","author":"Levey","year":"2002","journal-title":"N Engl J Med"},{"key":"R37-18-20210202","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"issue":"Suppl 6","key":"R38-18-20210202","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/00005344-199015061-00005","article-title":"Some old and new ideas on kinin metabolism.","volume":"15","author":"Erdos","year":"1990","journal-title":"J Cardiovasc Pharmacol"},{"key":"R39-18-20210202","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","article-title":"EURopean trial on reduction of cardiac events with Perindopril in stable coronary artery disease investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).","volume":"362","author":"Fox","year":"2003","journal-title":"Lancet"},{"key":"R40-18-20210202","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1161\/CIRCULATIONAHA.105.548461","article-title":"Long-term effects of ramipril on cardiovascular events and on diabetes.","volume":"112","year":"2005","journal-title":"Circulation"},{"key":"R42-18-20210202","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","article-title":"Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"R43-18-20210202","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1161\/01.CIR.103.7.919","article-title":"Effects of ramipril and vitamin E on atherosclerosis: the Study to Evaluate Carotid Ultrasound Changes in Patients Treated With Ramipril and Vitamin E (SECURE).","volume":"103","author":"Lonn","year":"2001","journal-title":"Circulation"},{"key":"R44-18-20210202","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0735-1097(02)01755-2","article-title":"Radial, carotid and aortic distensibility in congestive heart failure: effects of high-dose angiotensin-converting enzyme inhibitor or low-dose association with angiotensin type 1 receptor blockade.","volume":"39","author":"Giannattasio","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R45-18-20210202","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0002-9149(01)01461-8","article-title":"The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function.","volume":"87","author":"Pitt","year":"2001","journal-title":"Am J Cardiol"},{"key":"R46-18-20210202","doi-asserted-by":"crossref","first-page":"102","DOI":"10.7326\/0003-4819-141-2-200407200-00008","article-title":"Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction: a class effect?","volume":"141","author":"Pilote","year":"2004","journal-title":"Ann Intern Med"},{"key":"R47-18-20210202","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0002-9149(02)02767-4","article-title":"Impact of ramipril versus other angiotensin-converting enzyme inhibitors on outcome of unselected patients with ST-elevation acute myocardial infarction.","volume":"90","author":"Wienbergen","year":"2002","journal-title":"Am J Cardiol"},{"key":"R48-18-20210202","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(99)10365-9","article-title":"Angiotensin II receptor antagonists.","volume":"355","author":"Burnier","year":"2000","journal-title":"Lancet"},{"key":"R49-18-20210202","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1345\/aph.19294","article-title":"Angiotensin II receptor blockers in patients with ACE inhibitor induced angioedema.","volume":"34","author":"Warner","year":"2000","journal-title":"Ann Pharmacother"},{"key":"R50-18-20210202","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(02)09895-1","article-title":"Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan.","volume":"360","author":"Dickstein","year":"2002","journal-title":"Lancet"},{"key":"R51-18-20210202","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N Engl J Med"},{"key":"R52-18-20210202","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa055202","article-title":"Major congenital malformations after first-trimester exposure to ACE inhibitors.","volume":"354","author":"Cooper","year":"2006","journal-title":"N Engl J Med"},{"key":"R53-18-20210202","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM200208223470820","article-title":"Bradykinin mediated angioedema.","volume":"347","author":"Nussberger","year":"2002","journal-title":"N Engl J Med"},{"key":"R54-18-20210202","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0002-9343(01)00642-8","article-title":"Life threatening hyperkalemia during combined therapy with angiotensin converting enzyme inhibitors and spironolactone.","volume":"110","author":"Schepkens","year":"2001","journal-title":"Am J Med"},{"key":"R55-18-20210202","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0272-6386(95)90632-0","article-title":"Angiotensin-converting enzyme inhibitors may cause renal dysfunction in patients on long-term lithium treatment.","volume":"25","author":"Lehmann","year":"1995","journal-title":"Am J Kidney Dis"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00045391-201001000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:39:28Z","timestamp":1618036768000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-201001000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e31815addd9","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}